These injectable drugs suppress appetite and regulate blood sugar to promote weight loss in patients with obesity or diabetes
Heres what scientists think is going on
What that transparency doesn't do is eliminate the category-level considerations every buyer in this space needs to work through in mid-2026: compounded medications aren't FDA-approved, the regulatory environment governing their availability continues to evolve, and the right platform for you depends on your clinical eligibility, state-specific availability, your own health history, and your comfort level with a fully online clinical management model
What is included: review by a board-certified obesity-medicine physician, medication, syringes and alcohol swabs, cold-packed FedEx 1-day air shipping, and portal or email messaging
Wegovy (semaglutide)." Novo Nordisk Pharmaceuticals Inc , SUPPL-29 (soln)/SUPP 6